Key facts
- Gabbi’s last known valuation is $15.0M (Jun 2022).
- It has raised $6.9M; the latest was Accelerator/Incubator in Feb 2025.
- Notable investors include Plug and Play Tech Center, Gaingels, Goodwater Capital, H/L Ventures, Catalyst by Wellstar — 39 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 39 names
- ·Watchlist + deal alerts for Gabbi
- ·The full record, as it builds
Funding rounds
No funding rounds for Gabbi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gabbi
Developer of a tumor prevention and early detection platform designed to help women understand and reduce their risk of breast cancer. The company's platform offers a risk calculator analysis for identifying breast cancer and also offers virtual chat, community support, and video appointments, enabling women to take proactive actions against cancer.
- Sector
- Healthcare
- HQ
- Portland, OR, United States
- Founded
- 2019
- Employees
- 30
- Website
- gabbi.com/
- Ownership
- Privately Held (backing)
Gabbi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gabbi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gabbi in its N-PORT filings yet. We sweep new filings monthly.